Coronavirus Notebook: Middle Ground Pricing As Moderna Reaches 100m Dose US Agreement

Plus, Evidence Accelerator Finds No Benefit With HCQ

 
• By Pink Sheet Team
  
Coronavirus COVID-19 medical test vaccine research and development concept. Scientist in laboratory study and analyze scientific sample of Coronavirus antibody to produce drug treatment for COVID-19.
Moderna Reaches Initial US Vaccine Supply, Option Deal • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Real-World Evidence

More from Clinical Trials